Shanghai Junshi Biosciences Co (FRA:8SJ) Moat Score: 5/10 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8SJ Shanghai Junshi Biosciences Co Ltd FRA:8SJ
59 GF Score
Price €1.95
GF Value €3.43
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Junshi Biosciences Co Moat Score?

Shanghai Junshi Biosciences Co FRA:8SJ -12.95% 59 Moat Score is 5 as of Jul. 18, 2026. GuruFocus rates FRA:8SJ with a GF Score™ of 59/100 and a GF Value™ of €3.43 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,396 Biotechnology companies, Shanghai Junshi Biosciences Co ranks better than 96.7% on this metric.

Shanghai Junshi Biosciences Co has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Shanghai Junshi Biosciences Co has Narrow Moat: Shanghai Junshi Biosciences has a solid narrow moat due to its valuable intellectual property and patents in the biotech sector. While it has some pricing power and R&D capabilities, it faces competition from larger pharmaceutical companies, limiting its moat strength.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Shanghai Junshi Biosciences Co might have Narrow Moat - Solid narrow moat.

Shanghai Junshi Biosciences Co  (FRA:8SJ) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Shanghai Junshi Biosciences Co Moat Score Related Terms

FRA:8SJ vs VRTX, REGN, ALNY: Moat Score Comparison

For the Biotechnology subindustry, Shanghai Junshi Biosciences Co's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Junshi Biosciences Co Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Junshi Biosciences Co's Moat Score distribution charts can be found below:

* The bar in red indicates where Shanghai Junshi Biosciences Co's Moat Score falls into.


FRA:8SJ
59GF Score
Shanghai Junshi Biosciences Co Ltd FRA:8SJ
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Shanghai Junshi Biosciences Co (FRA:8SJ) has a Moat Score of 5 as of Jul. 18, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Shanghai Junshi Biosciences Co ranks #46 out of 1396 companies in the Biotechnology industry, placing it in the top 3.3%.
Is Shanghai Junshi Biosciences Co's Moat Score too high?
Shanghai Junshi Biosciences Co's current Moat Score is 5. The Biotechnology industry median Moat Score is 2.00. Shanghai Junshi Biosciences Co's value of 5 is 150% above this industry median. Based on the distribution chart, Shanghai Junshi Biosciences Co ranks #46 out of 1396 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Junshi Biosciences Co has a GF Score™ of 59/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Junshi Biosciences Co's Moat Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Junshi Biosciences Co ranks #46 out of 1396 companies for Moat Score. This places Shanghai Junshi Biosciences Co in the top 3% of its industry — outperforming the majority of peers. The industry median Moat Score is 2.00. Shanghai Junshi Biosciences Co's value of 5 is 150% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,396 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Junshi Biosciences Co's current Moat Score of 5 is 150% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Junshi Biosciences Co's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Junshi Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Junshi Biosciences Co (FRA:8SJ) is currently considered Significantly Undervalued. The stock's GF Value™ is €3.43, compared to a current price of €1.95 — trading 43.1% below its estimated fair value. The current Moat Score is 5 and 150% above the Biotechnology industry median of 2.00. Shanghai Junshi Biosciences Co's overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Shanghai Junshi Biosciences Co (FRA:8SJ), the current Moat Score is 5 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Junshi Biosciences Co (FRA:8SJ) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Junshi Biosciences Co stock appears to be undervalued. The current stock price of €1.95 is trading 43.1% below its estimated GF Value™ of €3.43. GuruFocus considers Shanghai Junshi Biosciences Co to be Significantly Undervalued.

Key valuation signals for FRA:8SJ:

  • Moat Score: 5
  • GF Value™: €3.43 vs. price of €1.95 (43.1% below fair value)
  • GF Score™: 59/100 with 5 warning signs
  • Industry Position: 150% above the Biotechnology median (#46 of 1396)

No single metric tells the full story. See the FRA:8SJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Junshi Biosciences Co Business Description

Address No. 987 Cai Lun Road, Level 4, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN
Shanghai Junshi Biosciences Co Ltd is mainly involved in the discovery, development, and commercialisation of therapeutic drugs. It focuses on the development and commercialization of several kinds of drugs, ranging from monoclonal antibodies to various drug modalities, including small molecules, ADCs, bi-specific or multi-specific antibodies, fusion proteins, nucleic acid drugs, and vaccines, as well as the exploration of next-generation therapies, including those for cancer and autoimmune diseases. The Group's portfolio includes commercialized drugs such as Tuoyi, Junmaikang, Mindewei, and Junshida, as well as products in clinical studies or in the marketing application stage. Geographically, it derives maximum revenue from Mainland China, and the rest from USA, India, and other markets.
59GF Score

Get the complete analysis for FRA:8SJ

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.95
Price
€3.43
GF Value